{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:37:07Z","timestamp":1791805027462,"version":"4.3.4"},"reference-count":74,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jpet.2026.104325","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:51:27Z","timestamp":1774972287000},"page":"104325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multitarget microRNA sponge for pancreatic ductal adenocarcinoma: Simultaneous targeting of miR-21, miR-155, and miR-18a"],"prefix":"10.1016","volume":"393","author":[{"given":"Mahdi","family":"Karimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Motamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8969-4755","authenticated-orcid":false,"given":"Alireza","family":"Shafizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Mardani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0758-4710","authenticated-orcid":false,"given":"Ehsan","family":"Arefian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpet.2026.104325_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"10.1016\/j.jpet.2026.104325_bib2","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: advances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jpet.2026.104325_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41575-023-00840-w","article-title":"Therapeutic developments in pancreatic cancer","volume":"21","author":"Hu","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.jpet.2026.104325_bib4","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: a review","volume":"326","author":"Park","year":"2021","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jpet.2026.104325_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.4708","article-title":"Estimated projection of US cancer incidence and death to 2040","volume":"4","author":"Rahib","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"10242","key":"10.1016\/j.jpet.2026.104325_bib6","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer","volume":"395","author":"Mizrahi","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jpet.2026.104325_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-031621-024600","article-title":"Tumor microenvironment in pancreatic cancer pathogenesis and therapeutic resistance","volume":"18","author":"Sherman","year":"2023","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104325_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.189065","article-title":"Breaking the stromal barrier in pancreatic cancer: advances and challenges","volume":"1879","author":"Chakkera","year":"2024","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"19","key":"10.1016\/j.jpet.2026.104325_bib9","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.jpet.2026.104325_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713340","article-title":"Circulating microRNAs as potential biomarkers in pancreatic cancer-advances and challenges","volume":"24","author":"Seyhan","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"10409","key":"10.1016\/j.jpet.2026.104325_bib11","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0140-6736(23)01366-1","article-title":"NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial","volume":"402","author":"Wainberg","year":"2023","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jpet.2026.104325_bib12","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3390\/jcm14041129","article-title":"Current and emerging treatment options for pancreatic cancer: a comprehensive review","volume":"14","author":"Hayat","year":"2025","journal-title":"J Clin Med"},{"issue":"1\u20133","key":"10.1016\/j.jpet.2026.104325_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/17474124.2024.2322648","article-title":"Next-generation therapies for pancreatic cancer","volume":"18","author":"Buckley","year":"2024","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.jpet.2026.104325_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12113206","article-title":"\u201cOpen Sesame?\u201d: biomarker status of the human equilibrative nucleoside transporter-1 and molecular mechanisms influencing its expression and activity in the uptake and cytotoxicity of gemcitabine in pancreatic cancer","volume":"12","author":"Randazzo","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.jpet.2026.104325_bib15","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/md21050288","article-title":"Structural manipulations of marine natural products inspire a new library of 3-amino-1,2,4-triazine PDK inhibitors endowed with antitumor activity in pancreatic ductal adenocarcinoma","volume":"21","author":"Carbone","year":"2023","journal-title":"Mar Drugs"},{"issue":"14","key":"10.1016\/j.jpet.2026.104325_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/JCI191936","article-title":"Pancreatic ductal adenocarcinoma: the Everest of cancer biology","volume":"135","author":"Than","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jpet.2026.104325_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1386699","article-title":"Pancreatic ductal adenocarcinoma: the latest on diagnosis, molecular profiling, and systemic treatments","volume":"14","author":"Bugazia","year":"2024","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104325_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41580-018-0059-1","article-title":"Regulation of microRNA biogenesis and its crosstalk with other cellular pathways","volume":"20","author":"Treiber","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"10.1016\/j.jpet.2026.104325_bib19","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.3390\/ijms25073914","article-title":"MicroRNAs in pancreatic cancer: advances in biomarker discovery and therapeutic implications","volume":"25","author":"Madadjim","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpet.2026.104325_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1457875","article-title":"MicroRNAs: emerging biomarkers and therapeutic targets in pancreatic cancer","volume":"11","author":"Yuan","year":"2024","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.jpet.2026.104325_bib21","article-title":"MicroRNAs in pancreatic cancer drug resistance: mechanisms and therapeutic potential","volume":"12","author":"Dong","year":"2024","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"10.1016\/j.jpet.2026.104325_bib22","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1097\/MPA.0b013e3181ba82e1","article-title":"Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma","volume":"38","author":"Park","year":"2009","journal-title":"Pancreas"},{"issue":"3","key":"10.1016\/j.jpet.2026.104325_bib23","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3390\/ijms25031469","article-title":"Trials and tribulations of microRNA therapeutics","volume":"25","author":"Seyhan","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"17\u201318","key":"10.1016\/j.jpet.2026.104325_bib24","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1089\/hum.2024.113","article-title":"Advances in microRNA therapeutics: from preclinical to clinical studies","volume":"35","author":"Brillante","year":"2024","journal-title":"Hum Gene Ther"},{"issue":"11","key":"10.1016\/j.jpet.2026.104325_bib25","doi-asserted-by":"crossref","first-page":"554","DOI":"10.5483\/BMBRep.2017.50.11.179","article-title":"Rules for functional microRNA targeting","volume":"50","author":"Kim","year":"2017","journal-title":"BMB Rep"},{"issue":"18","key":"10.1016\/j.jpet.2026.104325_bib26","doi-asserted-by":"crossref","first-page":"9938","DOI":"10.1093\/nar\/gkad645","article-title":"On the rules of engagement for microRNAs targeting protein coding regions","volume":"51","author":"Sapkota","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"10.1016\/j.jpet.2026.104325_bib27","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.gastha.2024.08.002","article-title":"Blood-based microRNA biomarker signature of early-stage pancreatic ductal adenocarcinoma with lead-time trajectory in prediagnostic samples","volume":"3","author":"Treekitkarnmongkol","year":"2024","journal-title":"Gastro Hep Adv"},{"key":"10.1016\/j.jpet.2026.104325_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2025.1697875","article-title":"Molecular roles of microRNA-21 and exosomal miR-21 in gastrointestinal cancers: diagnostic, therapeutic, and drug resistance insights","volume":"12","author":"Wang","year":"2025","journal-title":"Front Mol Biosci"},{"issue":"18","key":"10.1016\/j.jpet.2026.104325_bib29","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.3390\/diagnostics15182285","article-title":"The evolving landscape of microRNAs in cholangiocarcinoma and pancreatic cancer","volume":"15","author":"Schneider","year":"2025","journal-title":"Diagnostics (Basel)"},{"issue":"22","key":"10.1016\/j.jpet.2026.104325_bib30","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.1128\/MCB.00941-08","article-title":"MicroRNA-155 is regulated by the transforming growth factor beta\/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA","volume":"28","author":"Kong","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"7","key":"10.1016\/j.jpet.2026.104325_bib31","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.3390\/ijms26072861","article-title":"Fine regulation of microRNAs in gene regulatory networks and pathophysiology","volume":"26","author":"Seida","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"7592","key":"10.1016\/j.jpet.2026.104325_bib32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.jpet.2026.104325_bib33","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.hpb.2024.02.001","article-title":"Evidence for molecular subtyping in pancreatic ductal adenocarcinoma: a systematic review","volume":"26","author":"Robertson","year":"2024","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jpet.2026.104325_bib34","article-title":"Pancreatic cancer subtyping \u2013 the keystone of precision treatment","volume":"16","author":"Fan","year":"2025","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.jpet.2026.104325_bib35","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nmeth1079","article-title":"MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells","volume":"4","author":"Ebert","year":"2007","journal-title":"Nat Methods"},{"issue":"8","key":"10.1016\/j.jpet.2026.104325_bib36","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/ng2079","article-title":"Target mimicry provides a new mechanism for regulation of microRNA activity","volume":"39","author":"Franco-Zorrilla","year":"2007","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.jpet.2026.104325_bib37","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.3390\/ijms26104535","article-title":"Therapeutic applications of poly-miRNAs and miRNA sponges","volume":"26","author":"Avenda\u00f1o-Portugal","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"7441","key":"10.1016\/j.jpet.2026.104325_bib38","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature11993","article-title":"Natural RNA circles function as efficient microRNA sponges","volume":"495","author":"Hansen","year":"2013","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.jpet.2026.104325_bib39","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","article-title":"The biogenesis, biology and characterization of circular RNAs","volume":"20","author":"Kristensen","year":"2019","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/j.jpet.2026.104325_bib40","doi-asserted-by":"crossref","DOI":"10.1093\/bioadv\/vbad093","article-title":"CircRNA-sponging: a pipeline for extensive analysis of circRNA expression and their role in miRNA sponging","volume":"3","author":"Hoffmann","year":"2023","journal-title":"Bioinform Adv"},{"issue":"7441","key":"10.1016\/j.jpet.2026.104325_bib41","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature11928","article-title":"Circular RNAs are a large class of animal RNAs with regulatory potency","volume":"495","author":"Memczak","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jpet.2026.104325_bib42","article-title":"Comprehensive analysis of LncRNA-miRNA-mRNA CeRNA network associated with umbilical cord blood PBMC in down syndrome","volume":"15","author":"Zeng","year":"2025","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jpet.2026.104325_bib43","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3390\/ijms27031400","article-title":"The multi-target lncRNA-miRNA-mRNA TRIAD in pancreatic cancer diagnosis and therapy","volume":"27","author":"Jeong","year":"2026","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.jpet.2026.104325_bib44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ymeth.2012.07.019","article-title":"Generation of miRNA sponge constructs","volume":"58","author":"Kluiver","year":"2012","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.jpet.2026.104325_bib45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-I","article-title":"A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V","volume":"184","author":"Vermes","year":"1995","journal-title":"J Immunol Methods"},{"issue":"12","key":"10.1016\/j.jpet.2026.104325_bib46","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1002\/eji.202170126","article-title":"Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)","volume":"51","author":"Cossarizza","year":"2021","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jpet.2026.104325_bib47","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/7651_2019_259","article-title":"Scratch wound healing assay","volume":"2109","author":"Martinotti","year":"2020","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jpet.2026.104325_bib48","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-1-4939-2547-6_17","article-title":"Dual luciferase gene reporter assays to study miRNA function","volume":"1296","author":"Cl\u00e9ment","year":"2015","journal-title":"Methods Mol Biol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104325_bib49","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104325_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagrm.2024.195073","article-title":"Competing endogenous RNAs network and therapeutic implications: new horizons in disease research","volume":"1868","author":"El-Ashmawy","year":"2025","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"3","key":"10.1016\/j.jpet.2026.104325_bib51","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/nprot.2006.238","article-title":"Analysis of apoptosis by propidium iodide staining and flow cytometry","volume":"1","author":"Riccardi","year":"2006","journal-title":"Nat Protoc"},{"issue":"12","key":"10.1016\/j.jpet.2026.104325_bib52","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1073\/pnas.74.12.5463","article-title":"DNA sequencing with chain-terminating inhibitors","volume":"74","author":"Sanger","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpet.2026.104325_bib53","first-page":"3923","article-title":"Agarose gel electrophoresis for the separation of DNA fragments","volume":"62","author":"Lee","year":"2012","journal-title":"J Vis Exp"},{"issue":"7","key":"10.1016\/j.jpet.2026.104325_bib54","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol"},{"issue":"4","key":"10.1016\/j.jpet.2026.104325_bib55","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"6","key":"10.1016\/j.jpet.2026.104325_bib56","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/clinchem\/hvaf043","article-title":"MIQE 2.0: revision of the minimum information for publication of quantitative real-time PCR experiments guidelines","volume":"71","author":"Bustin","year":"2025","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.jpet.2026.104325_bib57","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nprot.2007.30","article-title":"In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro","volume":"2","author":"Liang","year":"2007","journal-title":"Nat Protoc"},{"issue":"7","key":"10.1016\/j.jpet.2026.104325_bib58","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"issue":"8","key":"10.1016\/j.jpet.2026.104325_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.204","article-title":"New extensibility and scripting tools in the ImageJ ecosystem","volume":"1","author":"Gahm","year":"2021","journal-title":"Curr Protoc"},{"issue":"11","key":"10.1016\/j.jpet.2026.104325_bib60","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.jpet.2026.104325_bib61","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","article-title":"A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?","volume":"146","author":"Salmena","year":"2011","journal-title":"Cell"},{"issue":"7483","key":"10.1016\/j.jpet.2026.104325_bib62","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature12986","article-title":"The multilayered complexity of ceRNA crosstalk and competition","volume":"505","author":"Tay","year":"2014","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.jpet.2026.104325_bib63","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin Chem"},{"issue":"7","key":"10.1016\/j.jpet.2026.104325_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70354","article-title":"Decoding the pancreatic cancer microenvironment: the multifaceted regulation of microRNAs","volume":"15","author":"Ji","year":"2025","journal-title":"Clin Transl Med"},{"issue":"2","key":"10.1016\/j.jpet.2026.104325_bib65","doi-asserted-by":"crossref","DOI":"10.4172\/2155-9929.S3-002","article-title":"Metabolic profiling comparison of human pancreatic ductal epithelial cells and three pancreatic cancer cell lines using NMR based metabonomics","volume":"3","author":"Watanabe","year":"2012","journal-title":"J Mol Biomark Diagn"},{"key":"10.1016\/j.jpet.2026.104325_bib66","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1016\/j.csbj.2022.08.064","article-title":"Challenges in genomic analysis of model systems and primary tumors of pancreatic ductal adenocarcinoma","volume":"20","author":"Hyun","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"issue":"3","key":"10.1016\/j.jpet.2026.104325_bib67","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/nat.2018.0721","article-title":"Lipid nanoparticles enabling gene therapies: from concepts to clinical utility","volume":"28","author":"Kulkarni","year":"2018","journal-title":"Nucleic Acid Ther"},{"issue":"18","key":"10.1016\/j.jpet.2026.104325_bib68","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jpet.2026.104325_bib69","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41576-021-00439-4","article-title":"Drug delivery systems for RNA therapeutics","volume":"23","author":"Paunovska","year":"2022","journal-title":"Nat Rev Genet"},{"issue":"17","key":"10.1016\/j.jpet.2026.104325_bib70","doi-asserted-by":"crossref","first-page":"7509","DOI":"10.7150\/thno.77259","article-title":"Lipid nanoparticles for delivery of RNA therapeutics: current status and the role of in vivo imaging","volume":"12","author":"Jung","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jpet.2026.104325_bib71","article-title":"Gene therapy for spinal muscular atrophy: timing is key","volume":"47","author":"Servais","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"4","key":"10.1016\/j.jpet.2026.104325_bib72","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/cas.13965","article-title":"Development of miRNA-based therapeutic approaches for cancer patients","volume":"110","author":"Takahashi","year":"2019","journal-title":"Cancer Sci"},{"issue":"4","key":"10.1016\/j.jpet.2026.104325_bib73","article-title":"Targeted delivery of microRNA sponge short-hairpin RNA via Vir-inspired biotechnical vector: enhancing cancer therapy","volume":"24","author":"Rozbahani","year":"2025","journal-title":"Gene Exp"},{"key":"10.1016\/j.jpet.2026.104325_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101997","article-title":"Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in na\u00efve patients with spinal muscular atrophy and following switch from other therapies","volume":"59","author":"Pane","year":"2023","journal-title":"EClinicalMedicine"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526005240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526005240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T08:04:25Z","timestamp":1779955465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526005240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0022356526005240"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104325","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multitarget microRNA sponge for pancreatic ductal adenocarcinoma: Simultaneous targeting of miR-21, miR-155, and miR-18a","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104325"}}